Dial-in Number

  • One tap mobile
    +13126266799,,3231998494# US (Chicago)
    +13462487799,,3231998494# US (Houston)
  • Dial by your location
    +1 312 626 6799 US (Chicago)
    +1 346 248 7799 US (Houston)
    +1 669 900 6833 US (San Jose)
    +1 929 436 2866 US (New York)
    +1 253 215 8782 US
    +1 301 715 8592 US
    Meeting ID: 323 199 8494
    Find your local number:

Web session

HL7 Antitrust Policy

Professional Associations, such as HL7, which bring together competing entities are subject to strict scrutiny under applicable antitrust laws. HL7 recognizes that the antitrust laws were enacted to promote fairness in competition and, as such, supports laws against monopoly and restraints of trade and their enforcement. Each individual participating in HL7 meetings and conferences, regardless of venue, is responsible for knowing the contents of and adhering to the HL7 Antitrust Policy as stated in §05.01 of the Governance and Operations Manual (GOM).


Please include your organization in your Zoom name.

  • Click on your picture/name in Zoom
  • Click on rename
  • enter <name> - <organization>
Danielle BancroftBest Practice Software
Melva Peters Jenaker Consulting
Jean Duteau (Chair)Duteau Designx
John Hatem (Scribe)Independent Consultantx
Scott Robertson Kaiser Permanente
Christof GessnerHL7 Germany
Corey SpearsMITREx
Dave HillMITRE
Frank McKinneyPOCPx
Isaac VetterEpic
Smile CDR
Lawrence LoColumbia University HIT Student
Margaret WeikerNCPDP
Matt SzczepankiewiczEpic
Peter SergentHL7 New Zealand
Reed D. GelzerTrustworthy EHR
Shelly SpiroPharmacy HIT Collaborative
Stephen ChuADHAx
Tim McNeilSurescriptsx
Kim RobertsPharmacy HIT Collaborativex
Kent BulzaWell Healthx
Phung Matthews3Mx
Jack BrashierEpic
Emmanuel Obasuyi

Joel MontavonPQA
Robb YoungPharmID
Christopher Isong

Gary SchoettmerNetRxx
Courtney BlandCVS / Aetna
Mark NeumuthAetna
Ed MillikanFDA
Sanket RavalCVS / Aetna

Agenda Items and Notes

Outstanding Action Item List

Meeting Notes from previous meeting

Project Review

Project Proposals

Project Scope Statements

External Meeting Review

Catalog Updates (John Hatem)

  •  John Hatem to follow up with Catalog folks to see when Pharmacy and Catalog folks can meet to discuss the Pharmacy specific catalog work. 

Workflow Update (John Hatem) 

  •  Discussed Contact resource states.  No Pharmacy impact at this time.  Over the last few meetings the Contract issues have continued to be discussed. 

Healthcare Product Update (John Hatem)

  •  Discussing trackers.  Pharmacy may be interested in the FHIR -37742 tracker which discusses updates to the definitions of supplier, distributor and dispensor and other terms rolled into this tracker.   

EHR conformant reconciled medication list (cRML) (Scott Robertson / John Hatem)

NCPDP Updates (NCPDP Members)

All NCPDP Meeting information can be obtained at

WG18 Patient Consent TG:

    • specification is in the ballot for September
    • ballot comments to be reviewed

MC Consumer and Provider RTPB Standards Monitoring Sub-Task Group

  • group is on hiatus
  • No new HL7 work at this time, but NCPDP is working on some content that may make it way to HL7 in the future.  This is not a committment, just a heads up. 


PDex Formulary (Corey)

    • Publication Request - approved by eVote

Pharmacist Consult Note (Scott)

    • Ballot content approved and content submitted

Trackers - link to pharmacy unresolved Jira trackers (see trackers for details / resolutions)

  • FHR-37361 tracker discussed.  Updated descriptions - see tracker for details.  Motion to accept changes was made by John Hatem and seconded by Tim McNeil.  Vote passed:  8-0-0

Any Other Business

  • Informal survey - 4 members plan on attending the Sept WGM. 

Next meeting: